Skip to content
Search

Latest Stories

Armstrong’s Pharmacy sold after 67 years of family ownership

The high dispensing Sheffield pharmacy has been owned by the Armstrong family since 1957

The high dispensing Sheffield pharmacy has been owned by the Armstrong family since 1957 

Armstrong’s Pharmacy in Sheffield, South Yorkshire has been sold for the first time in 67 years for an undisclosed price.

Located on the corner of Gleadless Road, three miles south-west of Sheffield City Centre, the pharmacy dispenses an average of 11,332 items per month, according to Christie and Co, the broker that facilitated the sale.


Owned and operated by the Armstrong family since 1957, the business has been acquired by a husband-and-wife team of first-time buyers.

The new owners, whose identities were not disclosed, plan to expand the pharmacy by adding more consultation rooms and increasing services offered to the local community.

Chris Armstrong, the previous owner, ran the business with his wife Jane before deciding to sell in preparation for their retirement.

Commenting on the sale, Chris said: “It was a big decision to sell our multigenerational business but, when it was time to retire, we were glad that Christie and Co were able to quickly market the business successfully.”

“We had three viewings and three offers in the first few weeks of marketing, and it is pleasing that the new owners are a young, motivated husband and wife team with plans to enhance what we have done with the business as a family. We wish them all the very best and we are looking forward to our retirement.”

Tom Young, senior business agent – pharmacy at Christie and Co, described Armstrong’s Pharmacy as “a fantastic example of a well-run independent community pharmacy with good margins, a well-drilled team, and owners who really worked hard to provide top-class service to their community.”

He added that, as the supply of these types of opportunities across South Yorkshire has been limited in recent years, they were inundated with enquiries from first-time buyers and existing operators alike, when we launched the business to market, which was expected.

“We look forward to seeing the new owners take what the Armstrong family has built over many years and enhance that with their own ideas,” he added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less